IMARC Group's report titled "Positron Emission Tomography (PET) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032". The global positron emission tomography market size reached US$ 1,084 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,512 Million by 2032, exhibiting a growth rate (CAGR) of 5.9% during 2024-2032.

Factors Affecting the Growth of the Global Positron Emission Tomography Industry:

• Increasing Focus on Personalized Medicine:

The shift toward personalized medicine, characterized by tailored treatment approaches based on individual patient characteristics, is fueling the growth of the PET market. PET imaging enables clinicians to assess disease heterogeneity, predict treatment response, and monitor therapeutic efficacy at the molecular level, facilitating personalized treatment decisions. With advancements in radiopharmaceutical development and molecular imaging probes, PET imaging techniques continue to evolve, offering greater specificity and sensitivity for detecting biomarkers and molecular targets associated with various diseases. As personalized medicine becomes increasingly integrated into clinical practice, the demand for PET technology is expected to rise, driving market expansion and innovation in the field.

• Growing Prevalence of Cancer:

The rising prevalence of cancer and neurological disorders worldwide is driving the demand for PET imaging. PET scans play a crucial role in cancer staging, treatment planning, and response assessment by providing valuable information on tumor metabolism and localization. Additionally, PET imaging is increasingly used in the diagnosis and management of neurological conditions such as Alzheimer's disease, Parkinson's disease, and epilepsy, contributing to the expansion of the PET market as healthcare providers prioritize early detection and personalized treatment strategies.

• Technological Advancements:

Continuous advancements in medical imaging technology are a significant driver of the (PET) market. PET scanners have evolved to offer higher resolution, faster scanning times, and improved image quality, enabling more accurate diagnosis and treatment monitoring across a range of medical specialties. The integration of hybrid imaging systems, such as PET/CT and PET/MRI, further enhances diagnostic capabilities by combining metabolic information from PET with anatomical details from other imaging modalities, leading to better patient outcomes and driving the demand for PET technology.

Leading Companies Operating in the  Industry:

• Agfa Healthcare (Dedalus Group)
• GE Healthcare
• Koninklijke Philips NV
• Neusoft Medical Systems
• Positron Corporation
• Oncovision (Bruker)
• Mediso Medical Imaging Systems Ltd.
• Siemens Healthineers AG
• Segami Corporation
• Hitachi Ltd.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/positron-emission-tomography-market/requestsample

Market Report Segmentation:

Breakup by Product Type:

• Full Ring PET Scanners
• Partial Ring PET Scanners

Based on the product type, the market is divided into full ring PET scanners and partial ring PET scanners.

Breakup by Detector Type:

• Bismuth Germanium Oxide (BGO)
• Lutetium Oxyorthosilicate (LSO)
• Lutetium Fine Silicate (LFS)
• Lutetium Yttrium Orthosilicate (LYO)
• Gadolinium Oxyorthosilicate (GSO)

On the basis of the detector type, the market is segmented into bismuth germanium oxide (BGO), lutetium oxyorthosilicate (LSO), lutetium fine silicate (LFS), lutetium yttrium orthosilicate (LYO), and gadolinium oxyorthosilicate (GSO).

Breakup by Application:

• Cardiology
• Neurology
• Oncology
• Others

Based on the application, the market is classified into cardiology, neurology, oncology, and others.  

Breakup by End-User:

• Hospitals and Clinics
• Diagnostic Centers
• Others

On the basis of the end user, the market is categorized into hospitals and clinics, diagnostic centers, and others.

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America holds the majority of market share as the region has a rich ecosystem of technology, growing prevalence of cancer, and developing healthcare infrastructure.

Global Positron Emission Tomography Market Trends:

Digital PET technology is revolutionizing the field of molecular imaging by offering improved sensitivity, spatial resolution, and image quality compared to traditional analog PET systems. Digital PET scanners utilize advanced detector technology and reconstruction algorithms to enhance image clarity and reduce image noise, enabling more accurate diagnosis and treatment planning. Besides, PET imaging is increasingly being used in neurology and cardiology for the diagnosis and management of various neurological and cardiovascular conditions. In neurology, PET scans play a crucial role in the early detection and differential diagnosis of neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and dementia.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163